Vaccination Coverage by Age 24 Months Among Children Born in 2015 and 2016 - National Immunization Survey-Child, United States, 2016-2018.


Journal

MMWR. Morbidity and mortality weekly report
ISSN: 1545-861X
Titre abrégé: MMWR Morb Mortal Wkly Rep
Pays: United States
ID NLM: 7802429

Informations de publication

Date de publication:
18 Oct 2019
Historique:
entrez: 18 10 2019
pubmed: 18 10 2019
medline: 19 10 2019
Statut: epublish

Résumé

The Advisory Committee on Immunization Practices (ACIP) recommends that children be vaccinated against 14 potentially serious illnesses during the first 24 months of life (1). CDC used data from the National Immunization Survey-Child (NIS-Child) to assess vaccination coverage with the recommended number of doses of each vaccine at the national, state, territorial, and selected local levels* among children born in 2015 and 2016. Coverage by age 24 months was at least 90% nationally for ≥3 doses of poliovirus vaccine, ≥1 dose of measles, mumps, and rubella vaccine (MMR), ≥3 doses of hepatitis B vaccine (HepB), and ≥1 dose of varicella vaccine, although MMR coverage was <90% in 20 states. Children were least likely to be up to date by age 24 months with ≥2 doses of influenza vaccine (56.6%). Only 1.3% of children born in 2015 and 2016 had received no vaccinations by the second birthday. Coverage was lower for uninsured children and for children insured by Medicaid than for those with private health insurance. Vaccination coverage can be increased by improving access to vaccine providers and eliminating missed opportunities to vaccinate children during health care visits. Increased use of local vaccination coverage data is needed to identify communities at higher risk for outbreaks of measles and other vaccine-preventable diseases.

Identifiants

pubmed: 31622284
doi: 10.15585/mmwr.mm6841e2
pmc: PMC6802679
doi:

Substances chimiques

Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

913-918

Déclaration de conflit d'intérêts

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Références

MMWR Morb Mortal Wkly Rep. 2018 Feb 09;67(5):156-157
pubmed: 29420458
MMWR Morb Mortal Wkly Rep. 2019 Oct 11;68(40):893-896
pubmed: 31600181
Expert Rev Vaccines. 2017 Nov;16(11):1107-1118
pubmed: 28914112
MMWR Morb Mortal Wkly Rep. 2018 Oct 12;67(40):1123-1128
pubmed: 30307907
Matern Child Health J. 2017 Dec;21(12):2178-2187
pubmed: 28755045
MMWR Morb Mortal Wkly Rep. 2017 Nov 03;66(43):1178-1181
pubmed: 29095809

Auteurs

Holly A Hill (HA)

Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC.

James A Singleton (JA)

Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC.

David Yankey (D)

Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC.

Laurie D Elam-Evans (LD)

Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC.

S Cassandra Pingali (SC)

Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC.

Yoonjae Kang (Y)

Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH